Molecular Modelling of Resveratrol Derivatives with SIRT1 for the Stimulation of Deacetylase Activity
- PMID: 37842901
- DOI: 10.2174/0115734099258321231003161602
Molecular Modelling of Resveratrol Derivatives with SIRT1 for the Stimulation of Deacetylase Activity
Abstract
Background: Resveratrol is a polyphenol that is found in plants and has been proposed to have a potential therapeutic effect through the activation of SIRT1, which is a crucial member of the mammalian NAD+ -dependent deacetylases. However, how its activity is enhanced toward specific substrates by resveratrol derivatives has not been studied. This study aimed to evaluate the types of interaction of resveratrol and its derivatives with SIRT1 as the target protein, as well as to find out the best ligand with the strangest interaction with SIRT1.
Materials and methods: In this study, we employed the extensive molecular docking analysis using AutoDock Vina to comparatively evaluate the interactions of resveratrol derivatives (22 molecules from the ZINC database) as ligands with SIRT1 (PDB ID: 5BTR) as a receptor. The ChemDraw and Chem3D tools were used to prepare 3D structures of all ligands and energetically minimize them by the MM2 force field.
Results: The molecular docking and visualizations showed that conformational change in resveratrol derivatives significantly influenced the parameter for docking results. Several types of interactions, including conventional hydrogen bonds, carbon-hydrogen bonds, Pi-donor hydrogen bonds, and Pi-Alkyl, were found via docking analysis of resveratrol derivatives and SIRT1 receptors. The possible activation effect of resveratrol 4'-(6-galloylglucoside) with ZINC ID: ZINC230079516 with higher binding energy score (-46.8608 kJ/mol) to the catalytic domain (CD) of SIRT1 was achieved at the maximum value for SIRT1, as compared to resveratrol and its other derivatives.
Conclusion: Finally, resveratrol 4'-(6-galloylglucoside), as a derivative for resveratrol, has stably interacted with the CD of SIRT1 and might be a potential effective activator for SIRT1.
Keywords: Alzheimer.; Molecular docking; SIRT1; age-related diseases; autophagy; resveratrol derivatives.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Assessing the performance of three resveratrol in binding with SIRT1 by molecular dynamics simulation and MM/GBSA methods: the weakest binding of resveratrol 3 to SIRT1 triggers a possibility of dissociation from its binding site.J Comput Aided Mol Des. 2019 Apr;33(4):437-446. doi: 10.1007/s10822-019-00193-0. Epub 2019 Feb 25. J Comput Aided Mol Des. 2019. PMID: 30805760
-
Caloric restriction mimetics: Pinostilbene versus resveratrol regarding SIRT1 and SIRT6 interaction.Adv Med Sci. 2025 Mar;70(1):44-50. doi: 10.1016/j.advms.2024.11.002. Epub 2024 Nov 29. Adv Med Sci. 2025. PMID: 39617052
-
Molecular architecture of the human protein deacetylase Sirt1 and its regulation by AROS and resveratrol.Biosci Rep. 2013 May 15;33(3):e00037. doi: 10.1042/BSR20120121. Biosci Rep. 2013. PMID: 23548308 Free PMC article.
-
Resveratrol in Various Pockets: A Review.Curr Top Med Chem. 2019;19(2):116-122. doi: 10.2174/1568026619666190301173958. Curr Top Med Chem. 2019. PMID: 30834833 Review.
-
Activators of Sirtuin-1 and their Involvement in Cardioprotection.Curr Med Chem. 2018;25(34):4432-4456. doi: 10.2174/0929867325666180214115438. Curr Med Chem. 2018. PMID: 29446717 Review.
Cited by
-
β-Hydroxybutyrate and melatonin suppress maladaptive UPR, excessive autophagy and pyroptosis in Aβ 1-42 and LPS-Induced SH-SY5Y cells.Mol Biol Rep. 2024 Jul 13;51(1):802. doi: 10.1007/s11033-024-09754-5. Mol Biol Rep. 2024. PMID: 39001949
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous